Unknown NA INTERVENTIONAL NCT01226264

Diffusion MRI; Predictive Value for Cervical Uterine Cancer Recurrence (s52647)

Diffusion MRI; Predictive Value for Cervical Uterine Cancer Recurrence.

Sponsor: Universitaire Ziekenhuizen KU Leuven

Conditions Diffusion-weighted MRI Recurrence Uterine Cervical Cancer

Interventions Diffusion weighted MRI (DW- MRI)

Updated 7 times since 2017 Last updated: Dec 1, 2015 Started: Nov 30, 2010 Primary completion: Dec 31, 2015 Completion: Apr 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01226264, this NA trial focuses on Diffusion-weighted MRI and Recurrence and remains ongoing. Sponsored by Universitaire Ziekenhuizen KU Leuven, it has been updated 7 times since 2010, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Nov 2022 — Jul 2024 [monthly]

Unknown Status NA
Jan 2021 — Nov 2022 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA

▶ Show 2 earlier versions

Feb 2018 — Jun 2018 [monthly]

Unknown Status NA

Status: Active Not Recruiting → Unknown Status
Jan 2017 — Feb 2018 [monthly]

Active Not Recruiting NA

First recorded

Nov 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universitaire Ziekenhuizen KU Leuven

Data source: Universitaire Ziekenhuizen KU Leuven

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Leuven, Belgium